Blood Test to Detect Early Sepsis in Emergency Patients
Part of Blood & lymphatic, Infections clinical trials.
This study tests whether a special blood test can help doctors quickly identify patients who have serious infections (sepsis) in the emergency department. The test looks at white blood cells that glow under fluorescent light to see if they can predict which patients are at highest risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You are being treated in an emergency department
- You have a suspected or confirmed infection that requires antibiotic treatment started within 24 hours of arriving at the ED
- A routine blood sample (EDTA tube) can be collected from you as part of your normal care
- You are willing to participate and have not objected to the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for early signs of dangerous blood clotting complications (called DIC) in patients admitted to intensive care with severe infection. Finding these signs early may help doctors treat the problem faster and improve outcomes.
This study aims to find new ways to quickly diagnose sepsis (a severe response to infection) in patients arriving at the emergency room. If successful, these new tests could help doctors start treatment faster.
This trial uses a blood fluorescence test to check for early signs of sepsis. It may help doctors diagnose sepsis faster, allowing for quicker treatment.
This trial is testing whether a new, highly sensitive blood test (droplet digital PCR) combined with genetic analysis can help doctors predict sepsis earlier in emergency room patients. This could lead to faster treatment and better outcomes.
This study is testing a new blood test that looks at how well your blood clots to see if it can help find sepsis (a severe response to infection) earlier. It is for adults who might have an infection, but you cannot be taking certain medications or have certain health conditions.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.